Also, in a group of early stage primary lung cancer patients with potentially resectable tumors (stage I/II/IIIa, n = 173), 7 KRAS (G12/G13) mutations and 1 EGFR L858R mutation were detected (Table 4). This evidence concerns the gene EGFR and lung cancer.